Seeking Alpha

Steve Rosenman's  Instablog

Steve Rosenman
Send Message
Mr. Rosenman has nearly 15-years executive experience in the health and wellness sectors, including weight loss, cosmetics skincare and nutrition, both Rx and OTC. Expertise areas include strategic market and product planning and corporate development (evaluation, recommendation and execution of... More
View Steve Rosenman's Instablogs on:
  • ACLS On Tear In 2013!

    If you follow my blogs you would have noted ACLS is out of my typical area of expertise, but I do happen to have a past history in consumer electronics and know many semiconductor commodity brokers. I recommended ACLS at $0.83 and we just touches $2.20 today. I would expect a continued run up to $4 through Q4. They are gaining back market share in a large and expanding market very quickly. Their new tools may force a competitor to acquire them. Will reiterate buy and target 12 mo. price to be $6.25

    Tags: ACLS
    Jul 30 4:21 PM | Link | 1 Comment
  • MORE POTENTIAL NEWS FOR AMRN

    Side note to followers, this is a record breaker for me, 3 different posts in one day on the same stock.

    Anyway, finally seeing a public announcement from Pfizer re: their substantial corporate and product line re-alignment/re-org which they are positioning as a game-changer. I believe they are now prime to go in terms of supporting this re-org with high-profile (multi-billion) investments.

    It's on...

    Tags: PFE, AMRN
    Jul 29 3:02 PM | Link | 7 Comments
  • Yet More New Developmetn Re; Amarin

    IP continues to go AMRN's way. Epanova patent argument rejected by USPTO. Not a typical non-final. It's a thumbs down, prior art response. Epanova has zero composition patents. AZN just wasted a few hundred million bucks.

    Tags: AMRN, OMTH
    Jul 29 1:11 PM | Link | 75 Comments
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.